Hai‐Zhi Bu

1.3k total citations
36 papers, 986 citations indexed

About

Hai‐Zhi Bu is a scholar working on Pharmacology, Spectroscopy and Molecular Biology. According to data from OpenAlex, Hai‐Zhi Bu has authored 36 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pharmacology, 14 papers in Spectroscopy and 13 papers in Molecular Biology. Recurrent topics in Hai‐Zhi Bu's work include Pharmacogenetics and Drug Metabolism (13 papers), Analytical Chemistry and Chromatography (11 papers) and Metabolomics and Mass Spectrometry Studies (6 papers). Hai‐Zhi Bu is often cited by papers focused on Pharmacogenetics and Drug Metabolism (13 papers), Analytical Chemistry and Chromatography (11 papers) and Metabolomics and Mass Spectrometry Studies (6 papers). Hai‐Zhi Bu collaborates with scholars based in United States, Canada and China. Hai‐Zhi Bu's co-authors include Esam A. Orabi, Susan Mikkelsen, Ping Kang, William F. Pool, Philip Teitelbaum, Kim Knuth, Lance Goulet, Deepak Dalvie, Ellen Y. Wu and Ronald G. Micetich and has published in prestigious journals such as Analytical Chemistry, The Journal of Physical Chemistry B and Cancer Research.

In The Last Decade

Hai‐Zhi Bu

34 papers receiving 931 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hai‐Zhi Bu United States 18 371 277 201 175 126 36 986
Yau Yi Lau United States 16 105 0.3× 153 0.6× 115 0.6× 77 0.4× 163 1.3× 24 738
Alexey V. Kuzikov Russia 15 252 0.7× 298 1.1× 157 0.8× 41 0.2× 237 1.9× 67 740
W.F. Bayne United States 20 144 0.4× 427 1.5× 222 1.1× 116 0.7× 43 0.3× 63 1.3k
Vineet Kumar United States 22 261 0.7× 300 1.1× 88 0.4× 302 1.7× 56 0.4× 57 1.4k
Rosa I. Sánchez United States 22 133 0.4× 498 1.8× 94 0.5× 105 0.6× 57 0.5× 50 1.4k
Hamid Hadi United States 24 199 0.5× 491 1.8× 107 0.5× 70 0.4× 92 0.7× 96 2.1k
Jingling Tang China 17 128 0.3× 274 1.0× 39 0.2× 93 0.5× 139 1.1× 42 1.1k
Akira Kagayama Japan 20 475 1.3× 278 1.0× 263 1.3× 365 2.1× 22 0.2× 45 1.3k
R.J. Stubbs United States 17 115 0.3× 291 1.1× 166 0.8× 77 0.4× 36 0.3× 27 1.0k
Vahid Panahi‐Azar Iran 19 92 0.2× 472 1.7× 220 1.1× 181 1.0× 29 0.2× 35 1.2k

Countries citing papers authored by Hai‐Zhi Bu

Since Specialization
Citations

This map shows the geographic impact of Hai‐Zhi Bu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai‐Zhi Bu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai‐Zhi Bu more than expected).

Fields of papers citing papers by Hai‐Zhi Bu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai‐Zhi Bu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai‐Zhi Bu. The network helps show where Hai‐Zhi Bu may publish in the future.

Co-authorship network of co-authors of Hai‐Zhi Bu

This figure shows the co-authorship network connecting the top 25 collaborators of Hai‐Zhi Bu. A scholar is included among the top collaborators of Hai‐Zhi Bu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai‐Zhi Bu. Hai‐Zhi Bu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Jiaying, et al.. (2025). Pharmacological action, mechanism and structure-activity relationship of traditional Chinese medicine polysaccharide in the treatment of Alzheimer's disease: A review. International Journal of Biological Macromolecules. 330(Pt 2). 148017–148017.
2.
Bu, Hai‐Zhi, William F. Pool, Geoffrey W. Peng, et al.. (2011). Pharmacokinetics, Distribution, and Metabolism of [14C]Sunitinib in Rats, Monkeys, and Humans. Drug Metabolism and Disposition. 40(3). 539–555. 85 indexed citations
3.
Bello, Carlo L., Hai‐Zhi Bu, Shem Patyna, et al.. (2007). A phase I mass-balance study to evaluate the metabolism and excretion of [14C]-sunitinib (SU11248) in healthy male subjects. Cancer Research. 67. 6 indexed citations
4.
Bu, Hai‐Zhi, William F. Pool, Ellen Y. Wu, & Bhasker V. Shetty. (2007). A Unique Example of Drug Metabolism: Tetra- and Penta-Oxygenation Reactions of Capravirine in Rats, Dogs and Humans. Drug Metabolism Letters. 1(1). 61–65. 1 indexed citations
5.
Bu, Hai‐Zhi, Ping Zhao, Deepak Dalvie, & William F. Pool. (2007). Identification of primary and sequential bioactivation pathways of carbamazepine in human liver microsomes using liquid chromatography/tandem mass spectrometry. Rapid Communications in Mass Spectrometry. 21(20). 3317–3322. 17 indexed citations
6.
Bu, Hai‐Zhi, Hovhannes J. Gukasyan, Lance Goulet, et al.. (2007). Ocular Disposition, Pharmacokinetics, Efficacy and Safety of Nanoparticle-Formulated Ophthalmic Drugs. Current Drug Metabolism. 8(2). 91–107. 60 indexed citations
7.
8.
Bu, Hai‐Zhi, Ping Kang, Alan Deese, Ping Zhao, & William F. Pool. (2005). HUMAN IN VITRO GLUTATHIONYL AND PROTEIN ADDUCTS OF CARBAMAZEPINE-10,11-EPOXIDE, A STABLE AND PHARMACOLOGICALLY ACTIVE METABOLITE OF CARBAMAZEPINE. Drug Metabolism and Disposition. 33(12). 1920–1924. 65 indexed citations
9.
Bu, Hai‐Zhi, William F. Pool, Ellen Y. Wu, et al.. (2004). METABOLISM AND EXCRETION OF CAPRAVIRINE, A NEW NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR, ALONE AND IN COMBINATION WITH RITONAVIR IN HEALTHY VOLUNTEERS. Drug Metabolism and Disposition. 32(7). 689–698. 14 indexed citations
10.
Bu, Hai‐Zhi, et al.. (2001). Practical aspects of liquid chromatography/electrospray tandem mass spectrometry for rapid identification of metabolites of a new antifungal agent SYN‐2836 in dog urine. Rapid Communications in Mass Spectrometry. 15(13). 1092–1100. 1 indexed citations
11.
Bu, Hai‐Zhi, et al.. (2001). High-throughput cytochrome P450 (CYP) inhibition screening via cassette probe-dosing strategy. Journal of Chromatography B Biomedical Sciences and Applications. 753(2). 321–326. 9 indexed citations
12.
13.
Bu, Hai‐Zhi, et al.. (2000). Novel sample preparation method facilitating identification of urinary drug metabolites by liquid chromatography–tandem mass spectrometry. Journal of Chromatography B Biomedical Sciences and Applications. 738(2). 259–265. 4 indexed citations
14.
15.
16.
17.
18.
Khan, Jehangir K., et al.. (1999). A rapid and reliable solid-phase extraction–LC/MS/MS assay for the determination of two novel human leukocyte elastase inhibitors, SYN-1390 and SYN-1396, in rat plasma. Journal of Pharmaceutical and Biomedical Analysis. 20(4). 697–703. 1 indexed citations
19.
Khan, Jehangir K., et al.. (1999). High-performance liquid chromatographic analysis of new triazole antifungal agent SYN-2869 and its derivatives in plasma. Journal of Pharmaceutical and Biomedical Analysis. 20(5). 791–797. 3 indexed citations
20.
Bu, Hai‐Zhi, Esam A. Orabi, & Susan Mikkelsen. (1997). Charge Transport in Ferrocene-Containing Polyacrylamide-Based Redox Gels. The Journal of Physical Chemistry B. 101(46). 9593–9599. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yau Yi Lau Breakdown of academic impact, for papers by Alexey V. Kuzikov Breakdown of academic impact, for papers by W.F. Bayne Breakdown of academic impact, for papers by Vineet Kumar Breakdown of academic impact, for papers by Rosa I. Sánchez Breakdown of academic impact, for papers by Hamid Hadi Breakdown of academic impact, for papers by Jingling Tang Breakdown of academic impact, for papers by Akira Kagayama Breakdown of academic impact, for papers by R.J. Stubbs Breakdown of academic impact, for papers by Vahid Panahi‐Azar
Rankless by CCL
2026